These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 10474742)

  • 1. Inhibition of advanced glycated end-products.
    Gandhi JS; Patel V
    Postgrad Med J; 1999 Jul; 75(885):446-7. PubMed ID: 10474742
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycated proteins in diabetes.
    Furth AJ
    Br J Biomed Sci; 1997 Sep; 54(3):192-200. PubMed ID: 9499597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis of diabetic nephropathy.
    Dronavalli S; Duka I; Bakris GL
    Nat Clin Pract Endocrinol Metab; 2008 Aug; 4(8):444-52. PubMed ID: 18607402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early and advanced non-enzymatic glycation products in the pathogenesis of diabetic kidney disease.
    Ziyadeh FN; Mogyorósi A; Kalluri R
    Exp Nephrol; 1997; 5(1):2-9. PubMed ID: 9052842
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetes and advanced glycoxidation end products.
    Huebschmann AG; Regensteiner JG; Vlassara H; Reusch JE
    Diabetes Care; 2006 Jun; 29(6):1420-32. PubMed ID: 16732039
    [No Abstract]   [Full Text] [Related]  

  • 6. [Advanced glycosylation end products or glycotoxins: under-evaluated components of diet?].
    Wautier JL
    Rev Prat; 2001 Sep; 51(13):1397-9. PubMed ID: 11601066
    [No Abstract]   [Full Text] [Related]  

  • 7. Advanced glycation in diabetic renal and vascular disease.
    Vlassara H
    Kidney Int Suppl; 1995 Sep; 51():S43-4. PubMed ID: 7474689
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioactive peptides control receptor for advanced glycated end product-induced elevation of kidney insulin receptor substrate 2 and reduce albuminuria in diabetic mice.
    Singh BK; Mascarenhas DD
    Am J Nephrol; 2008; 28(6):890-9. PubMed ID: 18566543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.
    Vlassara H; Bucala R; Striker L
    Lab Invest; 1994 Feb; 70(2):138-51. PubMed ID: 8139257
    [No Abstract]   [Full Text] [Related]  

  • 10. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications.
    Friedman EA
    Diabetes Care; 1999 Mar; 22 Suppl 2():B65-71. PubMed ID: 10097902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pathogenetic role of advanced glycation end products in diabetic nephropathy].
    Zhou J; Zhang Y; Lu HY
    Sheng Li Ke Xue Jin Zhan; 2009 Oct; 40(4):372-4. PubMed ID: 21417044
    [No Abstract]   [Full Text] [Related]  

  • 12. Growth promoter-induced inhibition of proteolytic activities in cultured kidney cells: potential impact in diabetic nephropathy.
    Ling H; Heidland A
    Clin Nephrol; 1996 Oct; 46(4):260-2. PubMed ID: 8905212
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of advanced glycation end-products in the development of atherosclerosis.
    Odetti P
    Ital Heart J; 2001 Sep; 2 Suppl 3():34S-36S. PubMed ID: 11593929
    [No Abstract]   [Full Text] [Related]  

  • 14. Regular moderate exercise reduces advanced glycation and ameliorates early diabetic nephropathy in obese Zucker rats.
    Boor P; Celec P; Behuliak M; Grancic P; Kebis A; Kukan M; Pronayová N; Liptaj T; Ostendorf T; Sebeková K
    Metabolism; 2009 Nov; 58(11):1669-77. PubMed ID: 19608208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term complications in diabetes mellitus: role of irreversible glycosylation products].
    Treskes M; Wolffenbuttel BH
    Ned Tijdschr Geneeskd; 1996 Jun; 140(25):1299-303. PubMed ID: 8710007
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.
    Huang Y; Lin S; Zhou J
    Chin Med J (Engl); 1998 Aug; 111(8):698-704. PubMed ID: 11245022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibitory effect of elastase on diabetic nephropathy in experimental diabetic mice].
    Fujii W
    Hokkaido Igaku Zasshi; 2002 Sep; 77(5):429-38. PubMed ID: 12404758
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential accumulation of advanced glycation end products in the course of diabetic retinopathy.
    Hammes HP; Alt A; Niwa T; Clausen JT; Bretzel RG; Brownlee M; Schleicher ED
    Diabetologia; 1999 Jun; 42(6):728-36. PubMed ID: 10382593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new perspective on therapeutic inhibition of advanced glycation in diabetic microvascular complications: common downstream endpoints achieved through disparate therapeutic approaches?
    Sourris KC; Harcourt BE; Forbes JM
    Am J Nephrol; 2009; 30(4):323-35. PubMed ID: 19556753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical detection of glycated beta- and gamma-crystallins in lens and their circulating autoantibodies (IgG) in streptozocin induced diabetic rat.
    Ranjan M; Nayak S; Rao BS
    Mol Vis; 2006 Sep; 12():1077-85. PubMed ID: 17093392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.